Presidio raises $27 million

Presidio Pharmaceuticals Inc. (San Francisco, Calif.) raised $27 million in a series B round, bringing the total raised in the round to $53.1 million. New investor New Leaf Venture Partners joined existing investors Panorama Capital; Baker Brothers; Ventures West; Bay City Capital; Nexus Medical Partners; and Sagamore Bioventures. ...